Fosfonet sodium (BioDeep_00000840204)

   


代谢物信息卡片


Fosfonet sodium

化学式: C2H5Na2O6P (201.961916)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(C(=O)[O-])P(=O)(O)[O-].O.[Na+].[Na+]
InChI: /p-2

描述信息

D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D018894 - Reverse Transcriptase Inhibitors
D004791 - Enzyme Inhibitors > D019384 - Nucleic Acid Synthesis Inhibitors
C471 - Enzyme Inhibitor > C29575 - DNA Polymerase Inhibitor
C254 - Anti-Infective Agent > C281 - Antiviral Agent

同义名列表

1 个代谢物同义名

Fosfonet sodium



数据库引用编号

5 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • K Yoshihara, S Hayakawa, N Nagaoka, T Okihara, Y Yoshida, B Van Meerbeek. Etching Efficacy of Self-Etching Functional Monomers. Journal of dental research. 2018 08; 97(9):1010-1016. doi: 10.1177/0022034518763606. [PMID: 29554434]
  • Eagappanath Thiruppathi, Mark K Larson, Gopinath Mani. Surface modification of CoCr alloy using varying concentrations of phosphoric and phosphonoacetic acids: albumin and fibrinogen adsorption, platelet adhesion, activation, and aggregation studies. Langmuir : the ACS journal of surfaces and colloids. 2015; 31(1):358-70. doi: 10.1021/la5038712. [PMID: 25495665]
  • Richard N Threlfall, Adrian G Torres, Angelika Krivenko, Michael J Gait, Marvin H Caruthers. Synthesis and biological activity of phosphonoacetate- and thiophosphonoacetate-modified 2'-O-methyl oligoribonucleotides. Organic & biomolecular chemistry. 2012 Jan; 10(4):746-54. doi: 10.1039/c1ob06614e. [PMID: 22124653]
  • Dóra Tombácz, Judit S Tóth, Pál Petrovszki, Zsolt Boldogkoi. Whole-genome analysis of pseudorabies virus gene expression by real-time quantitative RT-PCR assay. BMC genomics. 2009 Oct; 10(?):491. doi: 10.1186/1471-2164-10-491. [PMID: 19852823]
  • Robin Mathew, Sameera Kongara, Brian Beaudoin, Cristina M Karp, Kevin Bray, Kurt Degenhardt, Guanghua Chen, Shengkan Jin, Eileen White. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes & development. 2007 Jun; 21(11):1367-81. doi: 10.1101/gad.1545107. [PMID: 17510285]
  • Rolando A G Garcia, Liansheng Liu, Zhongyi Hu, Alexis Gonzalez, Reid W von Borstel, Joel A Saydoff. Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine. Brain research. 2005 Dec; 1066(1-2):164-71. doi: 10.1016/j.brainres.2005.10.056. [PMID: 16330000]
  • Claire E Brook, Wesley R Harris, Christopher D Spilling, Wang Peng, J Jonathan Harburn, Sujittra Srisung. Effect of ligand structure on the pathways for iron release from human serum transferrin. Inorganic chemistry. 2005 Jul; 44(14):5183-91. doi: 10.1021/ic050411m. [PMID: 15998048]
  • Elena A Shirokova, Maxim V Jasko, Anastasiya L Khandazhinskaya, Alexander V Ivanov, Dmitry V Yanvarev, Yury S Skoblov, Vladimir A Mitkevich, Eduard V Bocharov, Tatyana R Pronyaeva, Nina V Fedyuk, Marina K Kukhanova, Andrey G Pokrovsky. Uncharged AZT and D4T derivatives of phosphonoformic and phosphonoacetic acids as anti-HIV pronucleosides. Journal of medicinal chemistry. 2004 Jul; 47(14):3606-14. doi: 10.1021/jm0310176. [PMID: 15214788]
  • Vimolmas Lipipun, Masahiko Kurokawa, Rutt Suttisri, Pagorn Taweechotipatr, Pornpen Pramyothin, Masao Hattori, Kimiyasu Shiraki. Efficacy of Thai medicinal plant extracts against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral research. 2003 Nov; 60(3):175-80. doi: 10.1016/s0166-3542(03)00152-9. [PMID: 14638393]
  • Germana Dini, Silvia Funghini, Ewa Witort, Lucia Magnelli, Elena Fanti, Daniel B Rifkin, Mario Del Rosso. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential. Journal of cellular physiology. 2002 Oct; 193(1):64-72. doi: 10.1002/jcp.10152. [PMID: 12209881]
  • J L Grem, L K Yee, B Schuler, J M Hamilton, A P Chen, C Chabuk, F Grollman, M Grabenc, C J Allegra, C H Takimoto. N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology. 2001 Nov; 12(11):1581-7. doi: 10.1023/a:1013185125186. [PMID: 11822758]
  • K Amin, K Y Ng, C S Brown, M S Bruno, T D Heath. LDL induced association of anionic liposomes with cells and delivery of contents as shown by the increase in potency of liposome dependent drugs. Pharmaceutical research. 2001 Jul; 18(7):914-21. doi: 10.1023/a:1010971808006. [PMID: 11496949]
  • J S Kim, T D Heath. In vitro cytotoxic effect of N-(phosphonacetyl)-L-aspartic acid in liposome against C-26 murine colon carcinoma. Archives of pharmacal research. 2000 Apr; 23(2):167-71. doi: 10.1007/bf02975508. [PMID: 10836745]
  • P T Lieu, E K Wagner. The kinetics of VP5 mRNA expression is not critical for viral replication in cultured cells. Journal of virology. 2000 Mar; 74(6):2770-6. doi: 10.1128/jvi.74.6.2770-2776.2000. [PMID: 10684293]
  • R J Harte, J C Matthews, S M O'Reilly, D W Tilsley, S Osman, G Brown, S J Luthra, F Brady, T Jones, P M Price. Tumor, normal tissue, and plasma pharmacokinetic studies of fluorouracil biomodulation with N-phosphonacetyl-L-aspartate, folinic acid, and interferon alfa. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 May; 17(5):1580-8. doi: 10.1200/jco.1999.17.5.1580. [PMID: 10334547]
  • X R Jiang, G Jimenez, E Chang, M Frolkis, B Kusler, M Sage, M Beeche, A G Bodnar, G M Wahl, T D Tlsty, C P Chiu. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature genetics. 1999 Jan; 21(1):111-4. doi: 10.1038/5056. [PMID: 9916802]
  • C Y Chen, J Liou, L W Forman, D V Faller. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras. Cell death and differentiation. 1998 Nov; 5(11):984-95. doi: 10.1038/sj.cdd.4400448. [PMID: 9846185]
  • C J Langer, D Schaebler, E Sauter, D DeMaria, C Johnson, D M Reilly, J Clark, J Leighton, C Aks, S Litwin, J A Ridge. Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck. Head & neck. 1998 Aug; 20(5):385-91. doi: 10.1002/(sici)1097-0347(199808)20:5<385::aid-hed5>3.0.co;2-u. [PMID: 9663665]
  • M A Nassim, M R Rouini, M C Cripps, F H Shirazi, S Veerasinghan, J M Molepo, M Obrocea, D Redmond, S Bates, D Fry, D J Stewart, R Goel. Effects of PALA on the pharmacokinetics of 5-fluorouracil. Oncology reports. 1998 Jan; 5(1):217-21. doi: 10.3892/or.5.1.217. [PMID: 9458325]
  • C H Köhne, A Harstrick, W Hiddemann, P Schöffski, H Wilke, C Bokemeyer, B Dörken, H J Schmoll. Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II study. European journal of cancer (Oxford, England : 1990). 1997 Oct; 33(11):1896-9. doi: 10.1016/s0959-8049(97)00256-6. [PMID: 9470854]
  • B Goz, K F Bastow. A possible role for topoisomerase II in cell death and N-phosphonoacetyl-L-aspartate-resistance frequency and its enhancement by 1-beta-D-arabinofuranosyl cytosine and 5-fluoro-2'-deoxyuridine. Mutation research. 1997 Aug; 384(2):89-106. doi: 10.1016/s0921-8777(97)00016-5. [PMID: 9298118]
  • A R Kinsella, D Smith, M Pickard. Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage. British journal of cancer. 1997; 75(7):935-45. doi: 10.1038/bjc.1997.164. [PMID: 9083327]
  • M Pickard, A Kinsella. Influence of both salvage and DNA damage response pathways on resistance to chemotherapeutic antimetabolites. Biochemical pharmacology. 1996 Aug; 52(3):425-31. doi: 10.1016/0006-2952(96)00244-4. [PMID: 8687496]
  • K Y Hostetler, G D Kini, J R Beadle, K A Aldern, M F Gardner, R Border, R Kumar, L Barshak, C N Sridhar, C J Wheeler, D D Richman. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro. Antiviral research. 1996 Jun; 31(1-2):59-67. doi: 10.1016/0166-3542(96)00947-3. [PMID: 8793009]
  • A Hageboutros, G R Hudes, J Brennan, F Green, J Hoffman, F P LaCreta, J Colofiore, D S Martin, R F Ozols, P J O'Dwyer. Phase I trial of fluorouracil modulation by N-phosphonacetyl-L-aspartate and 6-methylmercaptopurine ribonucleoside. Cancer chemotherapy and pharmacology. 1996; 37(3):229-34. doi: 10.1007/bf00688321. [PMID: 8529282]
  • P R Wyde, D K Moore, D M Pimentel, H A Blough. Evaluation of the antiviral activity of N-(phosphonoacetyl)-L-aspartate against paramyxoviruses in tissue culture and against respiratory syncytial virus in cotton rats. Antiviral research. 1995 May; 27(1-2):59-69. doi: 10.1016/0166-3542(94)00080-r. [PMID: 7486959]
  • L Tessera, E Mucciolo, L Bertoni, E Giulotto. Selection of N-(phosphonacetyl)-L-aspartate resistant Chinese hamster mutants in the presence of the uridine uptake inhibitor dipyridamole. Anticancer research. 1995 Jan; 15(1):189-92. doi: NULL. [PMID: 7733632]
  • M G Guzmán, R Rodríguez, S Resik, M Alvarez, L Morier, A Castillo, G Kourí, P Maś. [The physicochemical characterization of the agents isolated during the outbreak of epidemic neuropathy in Cuba. I]. Revista cubana de medicina tropical. 1995; 47(1):32-5. doi: NULL. [PMID: 9805064]
  • A S Charvet, M Camplo, P Faury, J C Graciet, N Mourier, J C Chermann, J L Kraus. Inhibition of human immunodeficiency virus type 1 replication by phosphonoformate- and phosphonoacetate-2',3'-dideoxy-3'-thiacytidine conjugates. Journal of medicinal chemistry. 1994 Jul; 37(14):2216-23. doi: 10.1021/jm00040a014. [PMID: 8035429]
  • B Ramachandran, K Houben, Y Y Rozenberg, J R Haigh, A Varpetian, B D Howard. Differential expression of transporters for norepinephrine and glutamate in wild type, variant, and WNT1-expressing PC12 cells. The Journal of biological chemistry. 1993 Nov; 268(32):23891-7. doi: 10.1016/s0021-9258(20)80469-4. [PMID: 8226929]
  • J L Grem, N McAtee, S M Steinberg, J M Hamilton, R F Murphy, J Drake, T Chisena, F Balis, R Cysyk, S G Arbuck. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma. Cancer research. 1993 Oct; 53(20):4828-36. doi: NULL. [PMID: 8402669]
  • J Nelson, I A Qureshi, S Vasudevan, D S Sarma. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase. Chemico-biological interactions. 1993 Oct; 89(1):35-47. doi: 10.1016/0009-2797(93)03195-z. [PMID: 8221965]
  • Y Chen, B Goz, L Kirkman. An analysis of vincristine-resistance in BHK cells pretreated with 1-beta-D-arabinofuranosylcytosine. Anticancer research. 1993 Jan; 13(1):249-55. doi: . [PMID: 8476220]
  • M Loghman-Adham, M Szczepanska-Konkel, T P Dousa. Phosphate transport in brush border membranes from uremic rats. Response to phosphonoformic acid. Journal of the American Society of Nephrology : JASN. 1992 Dec; 3(6):1253-9. doi: 10.1681/asn.v361253. [PMID: 1477321]
  • M M Reddy, M H Grieco, G F McKinley, D M Causey, C M van der Horst, D M Parenti, T M Hooton, R B Davis, M A Jacobson. Effect of foscarnet therapy on human immunodeficiency virus p24 antigen levels in AIDS patients with cytomegalovirus retinitis. The Journal of infectious diseases. 1992 Sep; 166(3):607-10. doi: 10.1093/infdis/166.3.607. [PMID: 1323624]
  • P Reusser, J G Gambertoglio, K Lilleby, J D Meyers. Phase I-II trial of foscarnet for prevention of cytomegalovirus infection in autologous and allogeneic marrow transplant recipients. The Journal of infectious diseases. 1992 Sep; 166(3):473-9. doi: 10.1093/infdis/166.3.473. [PMID: 1323614]
  • M Loghman-Adham, T P Dousa. Dual action of phosphonoformic acid on Na(+)-phosphate cotransport in opossum kidney cells. The American journal of physiology. 1992 Aug; 263(2 Pt 2):F301-10. doi: 10.1152/ajprenal.1992.263.2.f301. [PMID: 1380774]
  • G Deray, C Katlama, C Jacobs. Treatment of CMV retinitis. The New England journal of medicine. 1992 Jun; 326(25):1702. doi: NULL. [PMID: 1317011]
  • M E Perry, M Rolfe, P McIntyre, M Commane, G R Stark. Induction of gene amplification by 5-aza-2'-deoxycytidine. Mutation research. 1992 May; 276(3):189-97. doi: 10.1016/0165-1110(92)90008-w. [PMID: 1374514]
  • N Harvey, H S Tenenhouse. Renal Na(+)-phosphate cotransport in X-linked Hyp mice responds appropriately to Na+ gradient, membrane potential, and pH. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1992 May; 7(5):563-71. doi: 10.1002/jbmr.5650070513. [PMID: 1319668]
  • I H Hall, O T Wong, A Sood, C K Sood, B F Spielvogel, R P Shrewsbury, K W Morse. Hypolipidaemic activity in rodents of boron analogs of phosphonoacetates and cyanoborane adducts of dialkyl aminomethylphosphonates. Pharmacological research. 1992 Apr; 25(3):259-70. doi: 10.1016/s1043-6618(05)80075-1. [PMID: 1518770]
  • J Nelson, I A Qureshi, S Vasudevan. [Mechanism of the effect of serine and threonine on ammoniagenesis and biosynthesis of orotate in the mouse]. Clinical and investigative medicine. Medecine clinique et experimentale. 1992 Apr; 15(2):113-21. doi: NULL. [PMID: 1591893]
  • M Loghman-Adham. Mechanisms of heterogeneity of Na(+)-Pi cotransport in superficial and juxtamedullary renal cortex. Biochimica et biophysica acta. 1992 Mar; 1105(1):67-74. doi: 10.1016/0005-2736(92)90163-g. [PMID: 1533161]
  • C A Wood. Foscarnet for CMV retinitis. Lancet (London, England). 1992 Feb; 339(8791):501. doi: 10.1016/0140-6736(92)91119-s. [PMID: 1346861]
  • H A al-Mahrouq, S A Kempson. Expression of rat renal sodium/phosphate cotransporter in Xenopus laevis oocytes. Biochimica et biophysica acta. 1992 Feb; 1104(1):83-6. doi: 10.1016/0005-2736(92)90134-8. [PMID: 1532329]
  • P S Lietman. Clinical pharmacology: foscarnet. The American journal of medicine. 1992 Feb; 92(2A):8S-11S. doi: 10.1016/0002-9343(92)90330-e. [PMID: 1371039]
  • J A Straw, T L Loo, C C de Vera, P D Nelson, W A Tompkins, S A Bai. Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat. Journal of acquired immune deficiency syndromes. 1992; 5(9):936-42. doi: NULL. [PMID: 1387417]
  • J Aschan, O Ringdén, P Ljungman, B Lönnqvist, S Ohlman. Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients. Scandinavian journal of infectious diseases. 1992; 24(2):143-50. doi: 10.3109/00365549209052604. [PMID: 1322557]
  • C Katlama, E Dohin, E Caumes, I Cochereau-Massin, C Brancon, M Robinet, O Rogeaux, R Dahan, M Gentilini. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens. Journal of acquired immune deficiency syndromes. 1992; 5 Suppl 1(?):S18-24. doi: NULL. [PMID: 1318363]
  • A Ryrfeldt, T Nordgren, J Lundström. Hypocalcemia induced by foscarnet (Foscavir) infusion in dogs. Fundamental and applied toxicology : official journal of the Society of Toxicology. 1992 Jan; 18(1):126-30. doi: 10.1016/0272-0590(92)90204-u. [PMID: 1534776]
  • C Blanshard. Treatment of HIV-related cytomegalovirus disease of the gastrointestinal tract with foscarnet. Journal of acquired immune deficiency syndromes. 1992; 5 Suppl 1(?):S25-8. doi: NULL. [PMID: 1318364]
  • M A Jacobson. Review of the toxicities of foscarnet. Journal of acquired immune deficiency syndromes. 1992; 5 Suppl 1(?):S11-7. doi: NULL. [PMID: 1534839]
  • N Kemeny, K Seiter, D Martin, C Urmacher, D Niedzwiecki, R C Kurtz, P Costa, M Murray. A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA). Annals of internal medicine. 1991 Dec; 115(12):946-51. doi: 10.7326/0003-4819-115-12-946. [PMID: 1824554]
  • A G Palestine, M A Polis, M D De Smet, B F Baird, J Falloon, J A Kovacs, R T Davey, J J Zurlo, K M Zunich, M Davis. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Annals of internal medicine. 1991 Nov; 115(9):665-73. doi: 10.7326/0003-4819-115-9-665. [PMID: 1656826]
  • R R MacGregor, A L Graziani, R Weiss, J E Grunwald, J G Gambertoglio. Successful foscarnet therapy for cytomegalovirus retinitis in an AIDS patient undergoing hemodialysis: rationale for empiric dosing and plasma level monitoring. The Journal of infectious diseases. 1991 Oct; 164(4):785-7. doi: 10.1093/infdis/164.4.785. [PMID: 1654363]
  • V Vachon, M C Delisle, R Laprade, R Béliveau. Reconstitution of the renal brush-border membrane sodium/phosphate co-transporter. The Biochemical journal. 1991 Sep; 278 ( Pt 2)(?):543-8. doi: 10.1042/bj2780543. [PMID: 1832858]
  • H S Tenenhouse, J Lee, N Harvey. Renal brush-border membrane Na(+)-sulfate cotransport: stimulation by thyroid hormone. The American journal of physiology. 1991 Sep; 261(3 Pt 2):F420-6. doi: 10.1152/ajprenal.1991.261.3.f420. [PMID: 1832265]
  • A Hoppe, J T Lin, M Onsgard, F G Knox, T P Dousa. Quantitation of the Na(+)-Pi cotransporter in renal cortical brush border membranes. [14C]phosphonoformic acid as a useful probe to determine the density and its change in response to parathyroid hormone. The Journal of biological chemistry. 1991 Jun; 266(18):11528-36. doi: . [PMID: 1828801]
  • M A Jacobson, W L Drew, J Feinberg, J J O'Donnell, P V Whitmore, R D Miner, D Parenti. Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS. The Journal of infectious diseases. 1991 Jun; 163(6):1348-51. doi: 10.1093/infdis/163.6.1348. [PMID: 1645385]
  • M A Jacobsen, C van der Horst, D M Causey, M Dehlinger, R Hafner, J Mills. In vivo additive antiretroviral effect of combined zidovudine and foscarnet therapy for human immunodeficiency virus infection (ACTG Protocol 053). The Journal of infectious diseases. 1991 Jun; 163(6):1219-22. doi: 10.1093/infdis/163.6.1219. [PMID: 1828075]
  • C L Swenson, S E Weisbrode, L A Nagode, K A Hayes, C L Steinmeyer, L E Mathes. Age-related differences in phosphonoformate-induced bone toxicity in cats. Calcified tissue international. 1991 May; 48(5):353-61. doi: 10.1007/bf02556155. [PMID: 1829019]
  • M A Jacobson, J G Gambertoglio, F T Aweeka, D M Causey, A A Portale. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. The Journal of clinical endocrinology and metabolism. 1991 May; 72(5):1130-5. doi: 10.1210/jcem-72-5-1130. [PMID: 1827127]
  • E A Petersen. Extrapulmonary cytomegalovirus disease in transplant patients. Transplantation proceedings. 1991 Apr; 23(2 Suppl 1):13-6. doi: NULL. [PMID: 1647557]
  • A R Kinsella, M S Haran. Decreasing sensitivity to cytotoxic agents parallels increasing tumorigenicity in human fibroblasts. Cancer research. 1991 Apr; 51(7):1855-9. doi: NULL. [PMID: 2004369]
  • H A al-Mahrouq, S A Kempson. Photoaffinity labeling of brush-border membrane proteins which bind phosphonoformic acid. The Journal of biological chemistry. 1991 Jan; 266(3):1422-7. doi: . [PMID: 1824842]
  • M A Jacobson, J J O'Donnell. Approaches to the treatment of cytomegalovirus retinitis: ganciclovir and foscarnet. Journal of acquired immune deficiency syndromes. 1991; 4 Suppl 1(?):S11-5. doi: NULL. [PMID: 1848616]
  • E S Casper, J Baselga, T B Smart, G B Magill, M Markman, A Ranhosky. A phase II trial of PALA + dipyridamole in patients with advanced soft-tissue sarcoma. Cancer chemotherapy and pharmacology. 1991; 28(1):51-4. doi: 10.1007/bf00684956. [PMID: 2040033]
  • S J Matthews, R J Cersosimo, M L Spivack. Zidovudine and other reverse transcriptase inhibitors in the management of human immunodeficiency virus-related disease. Pharmacotherapy. 1991; 11(6):419-48; discussion 448. doi: NULL. [PMID: 1722897]
  • J Matis, M Krivjanská. The synthesis of the major DNA-binding protein (ICP8) in cells infected with the strain HSZP or KOS of herpes simplex virus type 1. Acta virologica. 1991 Jan; 35(1):44-53. doi: . [PMID: 1683115]
  • P Chrisp, S P Clissold. Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs. 1991 Jan; 41(1):104-29. doi: 10.2165/00003495-199141010-00009. [PMID: 1706982]
  • R Béliveau, M Jetté, M Demeule, M Potier, J Lee, H S Tenenhouse. Different molecular sizes for Na(+)-dependent phosphonoformic acid binding and phosphate transport in renal brush border membrane vesicles. Biochimica et biophysica acta. 1990 Oct; 1028(2):110-6. doi: 10.1016/0005-2736(90)90146-f. [PMID: 2145976]
  • N Lewin, P Aman, B Akerlund, E Gustavsson, C Carenfelt, L Lejdeborn, G Klein, E Klein. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation. Immunology letters. 1990 Oct; 26(1):59-65. doi: 10.1016/0165-2478(90)90176-q. [PMID: 2177451]
  • H Beaufils, G Deray, C Katlama, E Dohin, D Henin, V Sazdovitch, C Jouanneau. Foscarnet and crystals in glomerular capillary lumens. Lancet (London, England). 1990 Sep; 336(8717):755. doi: 10.1016/0140-6736(90)92253-e. [PMID: 1975929]
  • G Osapay, P Körmöczy, I Szilágyi, J Kajtár, B Kiss. Synthesis of N-(phosphonoacetyl)-dipeptide derivatives and evaluation of their antihypertensive activity. Die Pharmazie. 1990 Sep; 45(9):666-8. doi: NULL. [PMID: 2178265]
  • C Camaioni Neto, J M Steim, P S Sarin, D K Sun, N N Bhongle, R K Piratla, J G Turcotte. Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochemical and biophysical research communications. 1990 Aug; 171(1):458-64. doi: 10.1016/0006-291x(90)91415-o. [PMID: 2144114]
  • H S Tenenhouse, J Lee, N Harvey, M Potier, M Jette, R Beliveau. Normal molecular size of the Na(+)-phosphate cotransporter and normal Na(+)-dependent binding of phosphonoformic acid in renal brush border membranes of X-linked Hyp mice. Biochemical and biophysical research communications. 1990 Aug; 170(3):1288-93. doi: 10.1016/0006-291x(90)90533-s. [PMID: 2143899]
  • G Deray, C Katlama, E Dohin. Prevention of foscarnet nephrotoxicity. Annals of internal medicine. 1990 Aug; 113(4):332. doi: 10.7326/0003-4819-113-4-332_1. [PMID: 2165372]
  • H S Tenenhouse, J Lee. Sulfate inhibits [14C]phosphonoformic acid binding to renal brush-border membranes. The American journal of physiology. 1990 Aug; 259(2 Pt 2):F286-92. doi: 10.1152/ajprenal.1990.259.2.f286. [PMID: 2143632]
  • R V Farese, M Schambelan, H Hollander, S Stringari, M A Jacobson. Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis. Annals of internal medicine. 1990 Jun; 112(12):955-6. doi: 10.7326/0003-4819-112-12-955. [PMID: 2160217]
  • M Levi. Heterogeneity of Pi transport by BBM from superficial and juxtamedullary cortex of rat. The American journal of physiology. 1990 Jun; 258(6 Pt 2):F1616-24. doi: 10.1152/ajprenal.1990.258.6.f1616. [PMID: 2141765]
  • M Levi, R E Cronin. Early selective effects of gentamicin on renal brush-border membrane Na-Pi cotransport and Na-H exchange. The American journal of physiology. 1990 May; 258(5 Pt 2):F1379-87. doi: 10.1152/ajprenal.1990.258.5.f1379. [PMID: 2159723]
  • C L Swenson, R A Sams, P J Polas, D F Michael, L E Mathes. Age-related differences in pharmacokinetics of phosphonoformate in cats. Antimicrobial agents and chemotherapy. 1990 May; 34(5):871-4. doi: 10.1128/aac.34.5.871. [PMID: 2141779]
  • J S Freiman, S M Murray, K Vickery, D Lim, Y E Cossart. Postexposure treatment of experimental DHBV infection: a new therapeutic strategy. Journal of medical virology. 1990 Apr; 30(4):272-6. doi: 10.1002/jmv.1890300408. [PMID: 2142501]
  • M Szczepanska-Konkel, A Hoppe, J T Lin, T P Dousa. Irreversible inhibition of renal Na(+)-Pi cotransporter by alpha-bromophosphonoacetic acid. The American journal of physiology. 1990 Apr; 258(4 Pt 1):C583-8. doi: 10.1152/ajpcell.1990.258.4.c583. [PMID: 2333944]
  • G Nyberg, I Blohmé, H Persson, C Svalander. Forscarnet-induced tubulointerstitial nephritis in renal transplant patients. Transplantation proceedings. 1990 Feb; 22(1):241. doi: NULL. [PMID: 2137949]
  • M K Hassanzadeh, F T Aweeka, S Wu, M A Jacobson, J G Gambertoglio. Determination of phosphonoformic acid in human plasma and urine by high-performance liquid chromatography with electrochemical detection. Journal of chromatography. 1990 Jan; 525(1):133-40. doi: 10.1016/s0378-4347(00)83386-1. [PMID: 2140113]
  • T J McMillan, T Kalebic, G R Stark, I R Hart. High frequency of double drug resistance in the B16 melanoma cell line. European journal of cancer (Oxford, England : 1990). 1990; 26(5):565-7. doi: 10.1016/0277-5379(90)90077-7. [PMID: 2144741]
  • L S Hollis, A V Miller, A R Amundsen, J E Schurig, E W Stern. cis-diamineplatinum (II) complexes containing phosphono carboxylate ligands as antitumor agents. Journal of medicinal chemistry. 1990 Jan; 33(1):105-11. doi: 10.1021/jm00163a018. [PMID: 2296007]
  • G Nyberg, C Svalander, I Blohmé, H Persson. Tubulointerstitial nephritis caused by the antiviral agent foscarnet. Transplant international : official journal of the European Society for Organ Transplantation. 1989 Dec; 2(4):223-7. doi: 10.1007/bf02414539. [PMID: 2560634]
  • B Löfgren, E Nordenfelt, B Oberg. Inhibition of RNA- and DNA-dependent duck hepatitis B virus DNA polymerase activity by nucleoside and pyrophosphate analogs. Antiviral research. 1989 Dec; 12(5-6):301-10. doi: 10.1016/0166-3542(89)90057-0. [PMID: 2483879]
  • M Szczepanska-Konkel, A N Yusufi, J T Lin, T P Dousa. Structural requirement of monophosphates for inhibition of Na+-Pi cotransport in renal brush border membrane. Biochemical pharmacology. 1989 Dec; 38(23):4191-7. doi: 10.1016/0006-2952(89)90514-5. [PMID: 2597189]
  • K Shiraki, T Okuno, K Yamanishi, M Takahashi. Phosphonoacetic acid inhibits replication of human herpesvirus-6. Antiviral research. 1989 Dec; 12(5-6):311-8. doi: 10.1016/0166-3542(89)90058-2. [PMID: 2561336]
  • V G Bain, H M Daniels, A Chanas, G J Alexander, R Williams. Foscarnet therapy in chronic hepatitis B virus E antigen carriers. Journal of medical virology. 1989 Oct; 29(2):152-5. doi: 10.1002/jmv.1890290214. [PMID: 2532240]
  • H S Tenenhouse, A H Klugerman, J L Neal. Effect of phosphonoformic acid, dietary phosphate and the Hyp mutation on kinetically distinct phosphate transport processes in mouse kidney. Biochimica et biophysica acta. 1989 Sep; 984(2):207-13. doi: 10.1016/0005-2736(89)90218-6. [PMID: 2527564]
  • W L Gray, R Yalamanchili, B Raengsakulrach, R P Baumann, J Staczek, D J O'Callaghan. Viral transcripts in cells infected with defective interfering particles of equine herpesvirus type 1. Virology. 1989 Sep; 172(1):1-10. doi: 10.1016/0042-6822(89)90101-3. [PMID: 2549705]
  • J Sjövall, S Bergdahl, G Movin, S Ogenstad, M Saarimäki. Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection. Antimicrobial agents and chemotherapy. 1989 Jul; 33(7):1023-31. doi: 10.1128/aac.33.7.1023. [PMID: 2528939]
  • A N Yusufi, H Moltaji, T P Dousa. Dexamethasone blocks adaptive increase of Na+-Pi cotransport in renal brush border membrane elicited by thyroid hormone. Biochemical and biophysical research communications. 1989 Jun; 161(3):1160-5. doi: 10.1016/0006-291x(89)91363-6. [PMID: 2525901]
  • P Lehoang, B Girard, M Robinet, P Marcel, L Zazoun, S Matheron, W Rozenbaum, C Katlama, I Morer, J O Lernestedt. Foscarnet in the treatment of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology. 1989 Jun; 96(6):865-73; discussion 873. doi: 10.1016/s0161-6420(89)32824-7. [PMID: 2544840]
  • B Matz. Herpes simplex virus causes amplification of recombinant plasmids containing simian virus 40 sequences. The Journal of general virology. 1989 Jun; 70 ( Pt 6)(?):1347-58. doi: 10.1099/0022-1317-70-6-1347. [PMID: 2543782]